Search
Close this search box.
    • Small Molecules
      • Discovery
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers
Search
Close this search box.

Share holder services

Physical shareholders

Coming soon

Information for holder of physical securities

Investor Contact and Grievances

Notification

Please note that if you have any dispute against a listed company and or its Registrar and Share Transfer Agent (RTA) on delay or default in processing your request, as per SEBI Circular dated 30.05.2022, you can file for arbitration with the Stock Exchanges.

For more details, please see the web links of the Stock Exchanges:-

BSE: https://tiny.cc/m1l2vz

NSE: https://tiny.cc/s1l2vz

Registrar and Share Transfer Agents (RTA)
Corporate Governance, Shareholder Grievance Redressal & Retail Shareholders

SEBI

Stock Exchanges

Your browser does not support this function.

To download, Please share your details

To view or email, Please share your details view

To download, Please share your details